Publications
59
Citations
1,141
Est. group size
—
Recurring co-author estimate
Active years
19
Publishing since 2007
Huaxin Zhou studies the molecular biology of liver diseases, particularly how proteins are chemically modified and how cell metabolism is rewired in conditions like fatty liver disease (MASH/NASH), liver fibrosis (scarring), and liver cancers such as hepatocellular carcinoma. A related line of work uses computer simulations to study how drug molecules bind to targets like the EGFR protein, aiding drug discovery. The research combines laboratory experiments, large-scale genetic/molecular ('multi-omics') data analysis, and computational modeling.
Publication activity has grown steadily over the past decade, rising from a couple of papers per year to a peak of eight in 2024, averaging about 4.8 per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- MYCBP2-mediated HNF4α ubiquitination reprogrammed lipid metabolism in MASH-associated hepatocellular carcinoma
Oncogene · 2025
- Identification of novel inhibitors for epidermal growth factor receptor tyrosine kinase using absolute binding free-energy simulations
International Journal of Biological Macromolecules · 2025
- TRIM25‐Mediated INSIG1 Ubiquitination Promotes MASH Progression Through Reprogramming Lipid Metabolism
Advanced Science · 2025
- Revealing and Distinguishing the Binding Sites of Agonists/Antagonists on the MrgprX2 by CMC-MD Strategy
Analytical Chemistry · 2025
- eQTL and multi-omics integration reveal PPIH as a prognostic and immunotherapeutic biomarker
Frontiers in Immunology · 2025
- KIF18A inactivates hepatic stellate cells and alleviates liver fibrosis through the TTC3/Akt/mTOR pathway
Cellular and Molecular Life Sciences · 2024
- Oxytocin alleviates liver fibrosis via hepatic macrophages
JHEP Reports · 2024
- Integrated multi-omic analysis identifies fatty acid binding protein 4 as a biomarker and therapeutic target of ischemia–reperfusion injury in steatotic liver transplantation
Cellular and Molecular Life Sciences · 2024
- Correction: HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
Biomarker Research · 2024
- lincRNA00907 promotes NASH progression by targeting miRNA-942-5p/TAOK1
Aging · 2024
- TRIM32-Mediated Ubiquitination of STING Promotes Glycolysis And Hepatocellular Carcinoma Progression
SSRN Electronic Journal · 2024
- MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function
Cell Death and Disease · 2023
- NOP2-mediated m5C Modification of c-Myc in an EIF3A-Dependent Manner to Reprogram Glucose Metabolism and Promote Hepatocellular Carcinoma Progression
Research · 2023
- HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
Biomarker Research · 2023
- Binding Thermodynamics of Fourth-Generation EGFR Inhibitors Revealed by Absolute Binding Free Energy Calculations
Journal of Chemical Information and Modeling · 2023
- Journal of Separation Science×3
- Proceedings of IMPRS×3
- Cell Death and Disease×2
- Cellular and Molecular Life Sciences×2
- Biomarker Research×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile